The Breakfast Club | Blood Test To Detect Cancer At ‘Stage 0’ | Health | Cancer Detection | News18
Ce nouveau test sanguin promet de prédire plusieurs types de cancer plus d’un an avant leur formation
Very Small Embryonic-Like Stem Cells Transform Into Cancer Stem Cells and are Novel Candidates for
‘Holy Grail’ health test to ID cancer a YEAR before tumours grow
A new blood test is designed to pick up specific markers which show changes in the behaviour of stem cells that are a precursor to cancer mutations.
‘Holy grail’ of cancer detection predicts tumors a year before they form: breakthrough
The future of cancer treatment — hailed as the “holy grail” of early detection — is now being put to the test.
How a Mumbai family’s research can help detect cancer early
Two weeks ago, Prerna Dhawan lost her life to stage IV lung cancer. Her husband and daughter Aarti, 20, are still in a daze as it all happened so fast. Dhawan, in her sixties, showed no symptoms. She went about her daily chores which included a walk in the park, reading books, doing the laundry and cooking elaborate meals.
Rewiring attitude & revolutioning cure for cancer
Ashish Tripathi’s Tzar Labs has engineered the first prognostic test for cancer which can detect the condition at Stage 0 – marking a giant step forward in its cure.
Is This a Breakthrough Moment in Cancer Detection? Tzar Labs Finds Blood-Based Test to Detect Cancer 
Breakthrough in blood test for cancer prognosis
A first-of-its-kind blood test that can detect whether cancer is absent, imminent, or present in different stages is on its way to the market. This is a claim made by brothers Ashish Tripathi and Anish Tripathi, who lead Singapore-based molecular diagnostic company Tzar Labs Pte. Ltd. and Mumbai-based Epigeneres Biotechnology Pvt. Ltd., respectively.
Early Cancer Detection: Breakthrough By Indian Start-Up
Indian scientists have achieved a breakthrough in early cancer detection. They have discovered a way of diagnosing cancer through a blood test. This test has been co-developed by Mumbai-based Epigeneres Biotechnology and Singapore-based Tzar Labs. NDTV speaks to those at the helm of these companies about this breakthrough.
Indian biotech startup reports early cancer detection breakthrough
A team of Indian scientists says it has achieved a stunning breakthrough in early cancer diagnosis with a discovery rooted in a contentious segment of cellular biology that, if validated by additional trials, holds vast market potential in a branch of therapeutic medicine worth tens of billions of dollars a year.
Biotech startups Tzar Labs, Epigeneres Biotechnology claim breakthrough in cancer detection using novel blood test
Biotech startups Tzar Labs and Epigeneres Biotechnology have co-developed a novel blood test called HrC, which can help in the detection of cancers even before symptoms or tumours start developing.
Breakthrough in cancer with blood test: Tzar Labs
Singapore based, Tzar Labs, a molecular diagnostic company, along with Mumbai-based Epigeneres Biotechnology, claimed an unprecedented breakthrough in early
Indian biotech startup claims breakthrough in early-stage cancer detection
Tzar Labs, a molecular diagnostic company in coordination with the Mumbai-based Epigeneres Biotechnology, has claimed to have developed a breakthrough blood test for early prognosis/diagnosis of cancer.
Tzar Labs, Epigeneres Biotechnology announce breakthrough in cancer detection
Tzar Labs, a specialised molecular diagnostic company based in Singapore, and Mumbai-based Epigeneres Biotechnology on Friday said that they’ve made an unprecedented breakthrough in early detection and prognosis/diagnosis of cancer.
Quest for Pan-Cancer Diagnosis/Prognosis Ends with HrC Test Measuring Oct4A in Peripheral Blood
Cancer is a devastating disease whose incidence has increased in recent times and early detection can lead to effective treatment. Existing detection tools suffer from low sensitivity and specificity, and are high cost, invasive and painful procedures. Cancers affecting different tissues, ubiquitously express embryonic markers including Oct-4A, whose expression levels have also been correlated to staging different types of cancer. Cancer stem cells (CSCs) that initiate cancer are possibly the ‘transformed’ and pluripotent very small embryonic-like stem cells (VSELs) that also express OCT-4A. Excessive self-renewal of otherwise quiescent, pluripotent VSELs in normal tissues possibly initiates cancer.
